Kymera Therapeutics

Director, New Product Strategy

Kymera Therapeutics$195K — $275K *
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • Advanced degree in scientific or engineering discipline preferred (PhD or MS in related fields).
  • 6+ years in biopharma strategy, commercial strategy, or life-sciences consulting; PhD candidates with fewer years may be considered.
  • Experience at a boutique life-sciences consultancy is strongly preferred, especially in new product planning.
  • Ability to understand complex biology and clinical trial designs and their commercial implications.
  • Fluency in market research creation and management of external vendors.
  • Experience creating patient-based forecasts and scenario analyses.
  • Excellent communication skills, capable of creating executive-ready presentations.

Responsibilities

  • Own early commercial strategy for assigned programs as a core team member.
  • Develop comprehensive market landscapes covering treatment paradigms and stakeholder decision drivers.
  • Collaborate with cross-functional teams to establish product profiles and evidence-generation priorities.
  • Lead indication prioritization by assessing scientific rationale and market attractiveness.
  • Design and conduct market research with diverse stakeholders to produce actionable insights.
  • Contribute to the evaluation of new targets and business development opportunities through integrated assessments.
  • Maintain competitor and market trend awareness to inform portfolio planning.

Benefits

  • Comprehensive benefits package offered, including performance-driven pay and bonuses.
  • Opportunity for equity participation in the company.
  • Professional development support and access to advanced tools for work efficiency.
Full Job Description


How you'll make an impact:
  • As a program core team member, own early commercial strategy for assigned programs.
  • Develop disease and market landscapes covering patient journey, treatment paradigms, unmet needs, stakeholder decision drivers, and sources of market disruption.
  • Partner with Clinical Development, Medical, Regulatory, Research, and Program Leadership to shape target product profiles and evidence-generation priorities that drive differentiation.
  • Lead indication prioritization and sequencing, weighing scientific rationale, epidemiology, competitive intensity, feasibility, market access, and commercial attractiveness.
  • Build market models, revenue forecasts, and risk-adjusted assessments to inform portfolio planning, investment decisions, and long-range planning.
  • Design and run primary and secondary market research with physicians, payers, and patients; translate findings into decision-ready recommendations.
  • Support evaluation of new targets, pipeline, lifecycle, and business development opportunities through integrated scientific and commercial assessment.
  • Maintain a forward-looking view of competitors, mechanisms, clinical programs, and emerging scientific trends relevant to Kymera's portfolio.
  • Identify key intelligence questions and competitive scenarios, distinguishing signal from noise and flagging implications for Kymera's programs.
  • Deliver concise news-flow updates and landscape syntheses to program teams and leadership, interpreting what changed, why it matters, and what should follow.
  • Attend key medical and scientific meetings to capture competitive data, synthesize in real time, and produce post-congress readouts.
  • Use Kymera's AI-enabled intelligence tools to accelerate monitoring, triage, and synthesis, while maintaining rigorous source validation and traceability.
  • Help improve CI processes, templates, taxonomies, and AI-supported workflows to deliver insights faster with less manual effort.
  • Serve as a trusted strategic partner to program teams and functional leaders, bringing an external market and competitor lens into development decisions.
  • Translate complex scientific, clinical, and financial information into crisp executive narratives and presentations.
  • Frame ambiguous business questions, define the analytical approach, and drive projects to clear decisions.
  • Contribute to Corporate Strategy priorities - portfolio strategy, long-range planning, investor analyses - as business needs evolve.


Skills and experience you'll bring:
  • Advanced degree in a scientific or engineering discipline strongly preferred (e.g., PhD or MS in biology, immunology, pharmacology, biomedical engineering, bioengineering, chemical engineering, or a related field).
  • 6+ years of relevant experience in biopharma strategy, new product planning, commercial strategy, competitive intelligence, market research, or life-sciences consulting; exceptional candidates with a PhD and somewhat fewer post-degree years may be considered.
  • Strong preference for experience at a boutique life-sciences strategy consultancy, with hands-on responsibility for new product planning, indication strategy, market opportunity assessment, competitive intelligence, forecasting, and/or portfolio strategy engagements.
  • Demonstrated ability to rapidly understand complex biology, mechanisms of action, clinical trial design, endpoints, and therapeutic landscapes and connect them to strategic and commercial implications.
  • Fluency in primary and secondary market research and comfort managing external vendors and expert interviews.
  • Experience building or critically evaluating patient-based forecasts, epidemiology models, scenario analyses, and commercial opportunity assessments.
  • Excellent written and verbal communication skills, including the ability to create concise, executive-ready PowerPoint materials and communicate effectively with scientific and senior business audiences.
  • High level of proficiency with Excel and PowerPoint; strong comfort adopting AI-enabled research, synthesis, and knowledge-management tools and using them responsibly.
  • Highly analytical, intellectually curious, organized, and proactive, with strong judgment and the ability to manage multiple evolving priorities in a small, fast-moving organization.


Compensation
  • Kymera offers a competitive compensation package that recognizes both results and capabilities through market-based, performance-driven pay.
  • The anticipated base salary range for this role is $195,000 - $275,000, with eligibility for annual bonus, equity participation, and comprehensive benefits.
  • Actual salary is based on a holistic evaluation of the specific role/level as well as each candidate's depth of experience and the capabilities they bring to the position.

About Kymera Therapeutics

Kymera Therapeutics is a clinical-stage biopharmaceutical company that is focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. The company's proprietary targeted protein degradation platform, Pegasus, is designed to harness the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on undruggable and difficult-to-drug targets. Kymera's initial programs are focused on oncology and immunology, with a goal of delivering transformative therapies for patients with previously untreatable diseases. Kymera was founded in 2015 and is headquartered in Cambridge, MA.
Learn more about Kymera Therapeutics
Size
75 employees
Market Cap
$1.4 billion
Industry
Founded
2017
NASDAQ

Similar Jobs

More Jobs at Kymera Therapeutics

More Pharmaceuticals & Biotech Jobs

Find similar Director, New Product Strategy jobs: